Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
90 hedge funds and large institutions have $205M invested in Taro Pharmaceutical Industries Ltd. in 2023 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 37 increasing their positions, 27 reducing their positions, and 5 closing their positions.
160% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 5
37% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 27
11% more capital invested
Capital invested by funds: $185M → $205M (+$20.4M)
10% more funds holding
Funds holding: 82 → 90 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
M
Murchinson
Toronto,
Ontario, Canada
|
+$2.36M |
| 2 |
Morgan Stanley
New York
|
+$2.2M |
| 3 |
BlackRock
New York
|
+$1.51M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$477K |
| 5 |
SO
STRS Ohio
Columbus,
Ohio
|
+$383K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
-$2.61M |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
-$2.28M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$1.15M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$1.05M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$637K |
TARO Hedge Fund Activity: Q4 2023 in Review
90 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q4 2023, worth a combined $205M — up 11% from $185M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new TARO positions and 5 closed out — a net gain of 8 holders — while 37 added to existing stakes and 27 trimmed.
The largest buyer was Murchinson, adding an estimated $2.36M. The largest seller was Cowen and Company, exiting entirely with an estimated $2.61M sold.
- 90 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q4 2023, up from 82 in Q3 2023.
- Funds reported $205M of Taro Pharmaceutical Industries Ltd. stock for Q4 2023, up 11% quarter-over-quarter.
- 13 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q4 2023 and 5 closed out, a net change of +8 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q4 2023 was Murchinson, an estimated $2.36M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q4 2023 was Cowen and Company, an estimated $2.61M sold.
Based on aggregated 13F filings for Q4 2023.